Germany approves third trial of COVID-19 vaccine candidate
Hundreds of potential COVID-19 vaccines are in various stages of development, with 41 prospects in human trials across the globe.
An individual dose of the filled SARS-CoV-2 vaccine candidate made by biotech company IDT Biologika in Dessau-Rosslau, Germany. June 24, 2020(photo credit: HARTMUT BOESENER/IDT BIOLOGIKA/HANDOUT VIA REUTERS)ByREUTERS
